Klewel  

Transatlantic Pitching session
June 19, 2009 - Boston (USA)

Alexis Bosman (UpCell)

Training and consulting on human embryonic stem cell research and development [Biotech].


Samuel Constant (Epithelix)

Provider of innovative in vitro solutions for respiratory diseases and chemical testing [Biotech].


Bettina Ernst (PreClin)

Development and validation of therapeutics against chronic inflammatory diseases [Biotech].


Patrizia Fisher (PearlTec)

PearlTec develops a medical device for Computed Tomography and Magnetic Resonance Imaging that allows a higher patient throughput, significantly increased image quality and improved patient comfort [Medtech].


Marc Gitzinger (BioVersys)

Our first antibacterial lead compound is in preclinical development and backed by an expanding discovery pipeline [Pharmaceuticals].
This video is not available.

Sadik Hafizovic (Zurich Instruments):

Zurich Instruments is an ETH spinoff developing and selling high-tech instrumentation for dynamic signal analysis. [Electrical engineering].


Sai Reddy (NanoImmune SA)

A Hepatitis C vaccine based on a proprietary nanoparticle vaccine technology [Biotech].


Stefan Tuchschmid (VirtaMed)

We will sell surgical simulators for minimalinvasive endoscopic surgery with unprecedented realism, using proprietary technology in combination with current computing hardware [Life Sciences, Medtech].


David Weill (PRIMEQUAL SA)

Innovative injector that fills the market gap between standard disposable syringes and multi use injection pens [Medtech].


Pierre-Jean Wipff (HelvaLab)

We propose innovative cell culture dishes for biotech, pharma and cosmetic research.


Pitch Session Intro
VentureLeaders2008 IT
VentureLeaders2008 BIO
MIT start-ups